McKenzie Kathryn B 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Award
Common Stock
2020-03-02+5,824→ 7,929 total - Tax Payment
Common Stock
2020-03-01−168→ 2,105 total - Award
Common Stock
2020-03-02$28.33/sh+37,514$1,062,772→ 37,514 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (37,514 underlying)
Holdings
- 40,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (40,000 underlying) - 25,000
Stock Option (Right to Buy)
Exercise: $9.07From: 2018-10-17Exp: 2022-10-18→ Common Stock (25,000 underlying) - 13,894
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (13,894 underlying)
Footnotes (5)
- [F1]Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock.
- [F2]On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.